99.03.01~2000.02.25 NYU medical center/Cornell Medical Center, Research Fellow
2000.03.01 ~ 현재 차의과학대학교, 분당차병원 교수
논문
7-1.Kwon J, Kang J, Jo A, Seo K, An D, Baykan MY, Lee JH, Kim NB, Eum H, Hwang S, Lee JM, Park W, AnHJ, Lee H, Park J, Choi JK. Single-cell mapping of combinatorial target antigens for CAR switches using logic gates. Nature Biotechnology.2023 (IF= 68.16)
7-2.Hwang S, Lim J, Kang H, Jeong J, Joung J, Heo J, Jung D, Cho K, AnHJ. Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy. Cell & Bioscience. 2023 13:17 ( IF=9.58)
7-3.Kim MJ, Jung D, Park JY, Lee SM, AnHJ.GLIS1 in cancer-associated fibroblasts regulates the migration and invasion of ovarian cancer cells. Inter J Mole Science2022. 23:2218 ( IF=6.20)
7-4.Kwon A, Jeong J, Par H, Hwang S, Kim G, Kang H, Heo J, Lee HJ, Kim T, AnHJ. miR-22-3p and miR-30e-5; are associated with prognosis in cervical squamous cell carcinoma. Inter J Mole Science2022. 23:5623 ( IF=6.20)
7-5.Jung D, Baek YS, Lee IJ, Kim KY, Jang H, Hwang S, Jung J, Moon Y, Park K, Choi Y, AnHJ.Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions. Journal of Experimental & Clinical Cancer Research. 2021.40:333 ( IF=11.16)
7-6.Kang H, Choi MC, Kim S, Jeong J, Kwon A, Kim T, Kim G, Joo WD, Park H, Lee C, Song SH, Jung SG, Hwang S, AnHJ. Usp19 and RPL23 as candidate prognostic markers for advanced-stage high-grade serous ovarian carcinomas. Cancers.2021,13;3976 (SCI, IF=6.63)
7-7.Hwang SH, Kwon AY, Jeong JY, Kim S, Kang H, Park J, Kim JH, Han OJ, Lim SM, AnHJ.Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer. Scientific Reports. 2020 10:643-50 ( SCI, IF= 4.37 )
7-.8Choi MC, Hwang SH, Kim S, Jung SG, Park H, Joo WK, Lee C, Kim TH, Kang H, AnHJ.Clinical impact of somatic variants in homologous recombination repair-related Genes in ovarian high-grade serous carcinoma. Cancer Res Treat.2020 Jan 6: (SCI, IF=4.67)
7-9.Park H, Hwang S, Jeong JY, Jung SG, Choi MC, Joo WD, Son SH, Lee C, AnHJ.Integrative analysis of transcription factors and microRNAs in ovarian cancer cell spheroids. Journal of Ovarian Research. 2020 12:16( SCIE, IF=3.91 )
7-10.Choi YH, Lim EJ, Kim SW, Moon YW, Park KS, AnHJ.IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells. Journal for immunotherapy of Cancer.2019, 7:168-79 (SCI, IF=13.75)